Product Information

POKONZA 10 MEQ PACKET is a brand product labeled by CarWin Pharmaceutical Associates LLC, priced at $28.2613 per EA under NDC 15370030560. Its NADAC has been published 88 times since Dec 18, 2024.

FDA first approved this application on Aug 19, 2015. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the Potassium Chloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

POKONZA 10 MEQ PACKET

Potassium Chloride
$28.2613per EA
High Outlier

Strength

.75 g/.79g

NDC

15370030560

Classification

Brand

Dosage Form

POWDER, FOR SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA208019

FDA Approved

8/19/2015

TE Code

AA

On Market Since

9/19/2023

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POKONZA 10 MEQ PACKET has been published 88 times since Dec 18, 2024, and over the history we have for it it has risen 7.8%. The table below summarizes its recorded NADAC range and movement.

Current price$28.2613 per EA
All-time high$28.4193 (Jul 15, 2026)
All-time low$26.1906 (Jan 22, 2025)
52-week high$28.4193
52-week low$27.4582
Median price$27.5002
Average price$27.5965
Largest weekly change+5.0% (Feb 26, 2025)
Weeks tracked88
Tracking sinceDec 18, 2024

Price History

1W

+0.2%

1M

+0.2%

3M

-0.6%

6M

+2.9%

1Y

+2.8%

3Y

N/A

5Y

N/A

All

+7.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POKONZA 10 MEQ PACKET?

The current National Average Drug Acquisition Cost (NADAC) for POKONZA 10 MEQ PACKET, manufactured by CarWin Pharmaceutical Associates LLC, is $28.2613 per EA (NDC 15370030560), effective Aug 19, 2026.

How has the price of POKONZA 10 MEQ PACKET changed over time?

Over the history we have for it, the NADAC for POKONZA 10 MEQ PACKET has risen 7.8%. It has been tracked across 88 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for POKONZA 10 MEQ PACKET?

Since Dec 18, 2024, the NADAC for POKONZA 10 MEQ PACKET has ranged from a low of $26.1906 (Jan 22, 2025) to a high of $28.4193 (Jul 15, 2026), with a median of $27.5002 per EA.

Are there cheaper alternatives to POKONZA 10 MEQ PACKET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as POKONZA 10 MEQ PACKET in a comparable dosage form, but none are currently priced below it.

Who manufactures POKONZA 10 MEQ PACKET?

POKONZA 10 MEQ PACKET (NDC 15370030560) is labeled by CarWin Pharmaceutical Associates LLC, and CMS classifies it as a brand product.